DNMT3A and neoplasm: According to genomic datasets derived from 123 CRC tumor specimens in this study (Figure 5), the number of PIK3CA and DNMT3A mutations was significantly increased in patients aged over 65 years (p = 0.032 and 0.039, respectively).